Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Merck Foundation and...

    Merck Foundation and Tata Memorial Centre signs MoU to build cancer care capacity in Africa

    Written by Ruby Khatun Khatun Published On 2018-04-25T10:00:47+05:30  |  Updated On 25 April 2018 10:00 AM IST
    Merck Foundation and Tata Memorial Centre signs MoU to build cancer care capacity in Africa

    Mumbai: Merck Foundation, the philanthropic arm of Merck KGaA Germany, and the Tata Memorial centre, a premier cancer center in India, announced the signing of an MOU, aimed to provide fellowship program to Africa candidates.


    This initiative is a part of Merck Foundation’s ‘Merck Cancer Access Program’ that has been initiated by the Merck Foundation to increase the limited number of oncologists across Africa.


    Dr RashaKelej, CEO of Merck Foundation said, “We are delighted to formalize today our collaboration with the Tata Memorial centre under the umbrella of newly launched Merck Foundation. We have started our collaboration in 2016, during these two years, we have provided more than 30 African doctors with one-year oncology fellowship at Tata Memorial Centre.We believe that our partnership with India has a long way to go and together we can play a vital role in Africa and Asia.”


    “I strongly believe that building capacity is the right strategy to improve cancer care since lack of professional skills is the key challenge in Africa and developing countries.” Dr. RashaKelej added.


    Prof. K.S Sharma, Director (Academics), Tata Memorial Centre said, “We are pleased to announce our partnership with Merck Foundation to supporting Merck Foundation in building cancer care capacity in Asian and African countries. The collaboration in the field of academics will effectively enhance the capabilities to prevent, detect and treat the rising cases of cancer in these countries.”


    “We are planning to expand the cancer care centres in more states like Punjab, UP, Andhra Pradesh, Bihar, and Assam. TMC will be able to train more doctors, nurses, and technicians from Low and middle-income countries.” he further added.


    In 2017 alone, MF initiated the following activities in partnership with academia, ministries of health and the offices of First Ladies in more than 35 countries:




    • Merck Cancer Access Program: Over 30 African physicians received oncology fellowship programmes spanning one to two years, in a bid to help increase the limited number of oncologists in Africa

    • Merck More Than A Mother: More than 50 candidates received three-month hands-on training to be embryologists and fertility specialists in Africa and Asia to improve quality, regulated and safe fertility care in developing countries

    • Merck Diabetes and Hypertension Awards: Over 50 medical postgraduates will receive a one-year online diploma in diabetes or preventive cardiovascular medicines, as part of the effort to establish a platform of diabetes and hypertension experts in Africa and Asia

    AfricacancerCollaborationdiabetesDr RashaKelejhypertensionMerckMerck FoundationMoUsignsTata Memorial CentreTMC
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok